Biogen (BIIB) Capital Expenditures (2009 - 2026)
Biogen's Capital Expenditures was $40.9 million in Q2 2026, up 53.8% from $26.6 million a year earlier but down 20.1% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Capital Expenditures (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's Capital Expenditures was $182.2 million through Jun 30, 2026, up 32.0% year-over-year; for FY2025, it was $153.8 million, up 0.1% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $153.7 million in FY2024 (-44.5%), $277 million in FY2023 (+15.3%), $240.3 million in FY2022 (-6.9%) and $258.1 million in FY2021 (-39.2%).
- Quarterly Capital Expenditures has moved between $26.6 million (Q2 2025) and $86.4 million (Q4 2022) over five years.
- Compared with a year earlier, Capital Expenditures has increased for four straight quarters, with growth averaging 0.4% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2023 (growth of 92.4%); the worst was Q3 2024 (a decline of 52.8%).
- Per Business Quant data, BIIB's Capital Expenditures in the three quarters before Q2 2026 was $51.2 million (Q1 2026), $43.9 million (Q4 2025) and $46.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | 40.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.90 Mn |
| Mar 31, 2026 | 51.20 Mn |
| Dec 31, 2025 | 43.90 Mn |
| Sep 30, 2025 | 46.20 Mn |
| Jun 30, 2025 | 26.60 Mn |
| Mar 31, 2025 | 37.10 Mn |
| Dec 31, 2024 | 39.30 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 45.90 Mn |
| Dec 31, 2023 | 65.20 Mn |
| Sep 30, 2023 | 74.20 Mn |
| Jun 30, 2023 | 71.00 Mn |
| Mar 31, 2023 | 66.60 Mn |
| Dec 31, 2022 | 86.40 Mn |
| Sep 30, 2022 | 59.10 Mn |
| Jun 30, 2022 | 36.90 Mn |
| Mar 31, 2022 | 57.90 Mn |
| Dec 31, 2021 | 51.60 Mn |
| Sep 30, 2021 | 42.00 Mn |
API Access
Biogen Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();